HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NiCE (Nasdaq: NICE) today announced the winners of its 2025 International Partner Awards at the Partner Summit events held in Croatia and Thailand. These honorees are helping our customers drive innovation, meet ambitious timelines, and deliver success in the new era of customer service automation with CXone Mpower. Winners were recognized across several categories. Standout partner wins included: UK&I Partner of the Year – A 23-year partnership excelling in.

HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NICE Actimize, a NICE (NASDAQ: NICE) business, today announced its information-packed agenda for ENGAGE 2025, the industry's premier financial crime and compliance industry event. To be held on June 17-18 at New York's Sheraton Times Square Hotel, NICE Actimize's ENGAGE will bring together financial institutions thought leaders and subject matter experts to discuss the technology advancements and best practices in financial crime fighting. More than 200 companies.

HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NICE Actimize, a NICE (NASDAQ: NICE) business, today announced that its market-leading SURVEIL-X Holistic Conduct Surveillance solution is now integrated with Actimize Intelligence, powerful Generative AI capabilities designed to ensure accurate and timely detection of market abuse and conduct risks across every type of regulated employee communication, from emails and chats to traditional voice calls. Created to address the growing complexities of financial crim.

First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure 1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial 4 ST. GALLEN, Switzerland , May 23, 2025 /PRNewswire/ -- CSL Vifor is pleased to announce that the National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending that sparsentan can be used in the NHS in England as an option to treat primary IgA nephropathy in adults with a urine protein excretion of 1.0 g/day or more, or a urine protein-to-creatinine ratio of 0.75 g/g or more.3 NICE has provided guidance to ensure that only patients responding to treatment continue.3 The decision follows authorisation from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) in April 2025.5 What this means in practice is that there is enough evidence to show that sparsentan provides benefits and value for money, so it can be used routinely if it is considered the most suitable treatment option in this population.3 Sparsentan must be funded in England within 90 days of final publication of this guidance3 which is expected to be 27 June 2025.

HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NICE (Nasdaq: NICE) is excited to announce Interactions International 2025, the premier customer experience (CX) event of the year, taking place July 1-2, 2025, at Allianz Stadium in Twickenham, London. This two-day conference will unite 1,000 industry leaders, customer experience (CX) professionals, experts and partners to explore the AI-powered innovations shaping the future of customer service. To register for Interactions International 2025, or to learn more.

HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (NASDAQ: NICE) today announced results for the first quarter ended March 31, 2025, as compared to the corresponding periods of the previous year. First Quarter 2025 Financial Highlights GAAP Non-GAAP Total revenue was $700.2 million and increased 6% Total revenue was $700.2 million and increased 6% Cloud revenue was $526.3 million and increased 12% Cloud revenue was $526.3 million and increased 12% Operating income was $148.2 million and increased 22% Operat.

HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (Nasdaq: NICE) will announce its first quarter 2025 results on Thursday, May 15, 2025, before the opening of the NASDAQ Stock Exchange. Later that day, management will host a conference call to discuss the results. 8:30 AM - Eastern 1:30 PM - UK 3:30 PM - Israel The call will be webcast live on the Company's website at https://www.nice.com/company/investors/upcoming-event. Please register with the relevant link for either the webcast or dial-in on our “upcom.

HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NICE (Nasdaq: NICE) today announced at ServiceNow's annual customer and partner event, Knowledge 2025, a strategic partnership with ServiceNow (NYSE: NOW), the AI platform for business transformation, to deliver end-to-end, fully automated customer service fulfillment. The partnership leverages NICE's industry-leading AI-powered customer service automation platform with the ServiceNow AI Platform and Customer Service Management (CSM) solution to provide organizat.

FREMONT, Calif.--(BUSINESS WIRE)--Movius, the leading global provider of secure, AI-powered, purpose-driven communications software, today announced it has partnered with NICE, a leading provider of communication compliance solutions, to integrate its MultiLine™ solution with NICE's NTR-X cloud, compliance recording and assurance solution. With this integration, NICE users in regulated financial services organizations will have even more options to maintain compliance via access to a secure, mo.